Learn more about whether ICU Medical, Inc. or Masimo Corporation is a better investment based on AAII's A+ Investor grades, ...

Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $5.00.

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...